Effect of oral administration of Pheretima aspergillum (earthworm) in rats with cerebral infarction induced by middle-cerebral artery occlusion

Afr J Tradit Complement Altern Med. 2012 Oct 1;10(1):66-82. eCollection 2012.

Abstract

We investigated the curative effect of Pheretima aspergillum (earthworm, PA) on rats with middle cerebral artery occlusion (MCAo). The MCAo-induced cerebral infarction was established and its underlying mechanisms by counting the infarction areas and evaluating the rats' neurological status. Immunostaining was used to test the expression of NeuN, and glial fibrillary acidic (GFAP), S100B, and brain-derived neurotrophic factor (BDNF) proteins. Our results showed that oral administration of PA for two weeks to rats with MCAo successfully reduced cerebral infarction areas in the cortex and striatum, and also reduced scores of neurological deficit. The PA-treated MCAo rats showed greatly decreased neuronal death, glial proliferation, and S100B proteins in the penumbra area of the cortex and in the ischemic core area of the cortex, but BDNF did not changed. These results demonstrated novel and detailed cellular mechanisms underlying the neuroprotective effects of PA in MCAo rats.

Keywords: Cerebral infarction; Middle cerebral occlusion; Neuroprotective effect; Pheretima aspergillum.

MeSH terms

  • Administration, Oral
  • Animals
  • Antigens, Nuclear / metabolism
  • Biological Products / pharmacology
  • Biological Products / therapeutic use*
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / pathology
  • Brain-Derived Neurotrophic Factor / metabolism*
  • Cerebral Infarction / drug therapy*
  • Cerebral Infarction / etiology
  • Cerebral Infarction / metabolism
  • Cerebral Infarction / pathology
  • Disease Models, Animal
  • Infarction, Middle Cerebral Artery / complications*
  • Male
  • Middle Cerebral Artery / pathology
  • Nerve Tissue Proteins / metabolism
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*
  • Oligochaeta*
  • Rats
  • Rats, Sprague-Dawley
  • S100 Calcium Binding Protein beta Subunit / metabolism

Substances

  • Antigens, Nuclear
  • Biological Products
  • Brain-Derived Neurotrophic Factor
  • Nerve Tissue Proteins
  • Neuroprotective Agents
  • Rbfox3 protein, rat
  • S100 Calcium Binding Protein beta Subunit
  • S100b protein, rat